Matthew J. Leonard

CIK: 0001773152

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (50.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ANIP

ANI PHARMACEUTICALS INC

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

ANIP
ANI PHARMACEUTICALS INC
May 21, 2026
Award(A)
Direct
4.4K shares-
ANIP
ANI PHARMACEUTICALS INC
Aug 25, 2025
Sale(S)
Direct
2.5K shares at avg. $90.62$229K
ANIP
ANI PHARMACEUTICALS INC
Aug 18, 2025
Sale(S)
Direct
6.9K shares at avg. $88.17$612K
ANIP
ANI PHARMACEUTICALS INC
May 22, 2025
Award(A)
Direct
4.3K shares-

		Type	Shares	Price		Ownership
May 21, 2026	ANIP ANI PHARMACEUTICALS INC	Award(A)	4,357	-	$0	Direct
Aug 25, 2025	ANIP ANI PHARMACEUTICALS INC	Sale(S)	2,528	$90.62	$229,087	Direct
Aug 18, 2025	ANIP ANI PHARMACEUTICALS INC	Sale(S)	6,937	$88.17	$611,635	Direct
May 22, 2025	ANIP ANI PHARMACEUTICALS INC	Award(A)	4,336	-	-	Direct

1-4 of 4 transactions

About Leonard Matthew J

Leonard Matthew J (SEC CIK 0001773152) files insider reports with the SEC as Director of ANI PHARMACEUTICALS INC (ANIP).

Signal8 holds 4 ownership filings by Leonard Matthew J, all Form 4s, filed between May 27, 2025 and Jun 10, 2026. Those filings report 4 transactions, from May 22, 2025 to May 21, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Leonard Matthew J's filings is in PRINCETON, NJ.

Recent filings by Leonard Matthew J

May 21, 2026: Grant or award of ANIP shares (Form 4, code A).
Aug 25, 2025: Open-market sale of ANIP shares (Form 4, code S).
Aug 18, 2025: Open-market sale of ANIP shares (Form 4, code S).
May 22, 2025: Grant or award of ANIP shares (Form 4, code A).

Other insiders filing for ANI PHARMACEUTICALS INC (ANIP)

CAREY STEPHEN P., SVP & CFO
Lalwani Nikhil, PRESIDENT & CEO
Cook Meredith, SR. VP, GENERAL COUNSEL & SEC.
Thoma Jeanne, Director
Gosebruch Henry O, Director
Gutwerg Ori, SVP, GENERICS

How to read Form 4 transaction codes